Filing Details
- Accession Number:
- 0001654954-17-011880
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-27 17:08:35
- Reporting Period:
- 2017-12-22
- Accepted Time:
- 2017-12-27 17:08:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1378624 | Cellular Biomedicine Group Inc. | CBMG | Biological Products, (No Disgnostic Substances) (2836) | 861032927 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651520 | Yihong Yao | 19925 Stevens Creek Blvd., Suite 100 Cupertino CA 95014 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-22 | 4,167 | $12.00 | 29,667 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares were purchased pursuant to that certain Share Purchase Agreement, dated December 15, 2017, by and among the issuer, the reporting person and two other officers of the issuer. The issuance of the shares was made in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.
- The amount does not include shares of common stock granted as part of the Restricted Stock Units under the Cellular Biomedicine Group, Inc. 2014 Stock Incentive Plan, which grant has been previously reported on the reporting person's Form 4.
Billionaire Hedge Funds
